nvp invests in seed-stage B2B software companies based on data-driven and thematically oriented convictions, reinforced by industry insights and relationships.  Our tight-knit team of investment professionals executes with a startup mindset, putting decades of operational experience to support entrepreneurs throughout the journey of building a business.

nvp capital

RLI was founded with a vision to bring value to early stage companies by partnering with them early and helping them with the creation, development, positioning, and execution of their early stage activities as well as with seed investment.  From their experience, working with early stage companies, they realized that there is a need for a seasoned team that can support the Founders by helping them develop and execute their business strategy and objectives in order to reduce risk and to accelerate success. They also realized, that these services are needed most at these stages and yet are least accessible to early stage companies.   They created  RLI to offer a  model  that combines both the support and seed funding that are  essential to the success of companies at the early stage phase. They are passionate about technology and the process of bringing early stage companies to life, that they have done many times ourselves. They have extensive experience in funding, structuring business models, driving product, business development and strategic marketing.

Real-Life Innovations

New York Angels is one of the largest and most active angel investment organizations.  Founded in 2004 as the successor organization to the NYNMA (New York New Media Association) Angel Investor Program, New York Angels is a membership organization of over 110 active angel investors and early stage venture capital funds. The group meets monthly to screen and present early stage technology companies, and its members have invested over $100 million since 2002 into over 90 ventures. In April of 2017, PItchbook identified New York Angels as #3 in their list of the 8 top VCs funding seed rounds of New York-based companies.  Among the NYA membership are nationally known angel investors including Esther Dyson and David S. Rose. The group has one full-time staff, reporting to an 11 person Board of Directors chaired by Brian S. Cohen. Dr. Elizabeth Lindsey is currently Program Director of New York Angels. Since 2012, the membership has increased by 66% and investment activity has grown by over 215%.   New York Angels concentrates on early stage investments in the range of $100,000 - $1,000,000, although it has led deals as large as $2 million. It receives over 2,200 financing applications annually, from which it selects 12-16 companies each month for an in-person screening, where all members of New York Angels are invited to attend. The group meets again for an Investment Breakfast at the end of the month, where 2-4 opportunities present to the membership with a goal to close their current investment round within two months. The group is considered a leader in the growing field of organized angel investing. It was the first member of the national Angel Capital Association, hosted the ACA Summit conference in 2006, and was the initial test group for the now-standard gust (Angelsoft) funding platform.  Membership as an investor in New York Angels is by invitation only, and members are required to commit to investing at least $50,000 annually in early stage technology deals, in addition to the group's $3,500 annual membership dues.  Requests for funding for entrepreneurial ventures may be self-submitted through the group's website. New York Angels charges no fees to entrepreneurs.

New York Angels

BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its new  $50 million Greenhouse Fund. They invest in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date they have committed more than $40 million to more than 50 seed-stage companies and 17 pre-seed companies. Their portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement monies.

BioAdvance

REDO Ventures provides an understanding deeply entrepreneurship, courage, taking a long-term view, risks, transparency, and honesty. We partner with founders early stage in all sectors of consumer technology.

REDO Ventures

SpringTide is a venture capital that provides investment in the health tech industry. The firm was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.

SpringTide Ventures

We provide early-growth stage capital to transformational venture-backed technology businesses.We believe in partnering with the very best entrepreneurs and top-tier early-stage investors to help build enduring technology companies. We operate under the premise that the only way to build a world class business is to always put the company first. We believe this ethos optimizes outcomes for our companies and Limited Partners alike.

Beni VC

Wellsheet

Wellsheet organizes clinical information with machine learning to predict and visualize the most relevant information for patient care in a physician-friendly format within the existing EHR (Electronic Health Record). By allowing providers to arrive at clinical insights faster, Wellsheet improves early intervention and hospital efficiency, with proven impact in a 10,000 physician health system in NJ. Wellsheet has partnered with major EHR vendors including Epic and Cerner to distribute the Wellsheet product through a SaaS-based model for health system customers.

Wellsheet is the leading provider of a Smart Electronic Health Record (EHR) User Interface (UI) solution that aims to reduce clinician burnout and increase efficiency and usability of EHRs. The company's technology utilizes artificial intelligence (AI) and machine learning algorithms to synthesize, summarize, and elevate relevant clinical data from EHRs like Cerner, Epic, or athenahealth, as well as other data sources.

Wellsheet Recognized as a Sample Vendor in Smart EHR UI in a Gartner Report

Enabling the health systems to seamlessly connect, exchange, and interpret shared data

Hospital Interoperability

Wellsheet AI-Powered Smart EHR UI Delivers Usability and ROI

Wellsheet is the leading provider of a Smart Electronic Health Record (EHR) User Interface (UI) solution that aims to reduce clinician burnout and increase efficiency and usability of EHRs. The company's technology utilizes artificial intelligence (AI) and machine learning algorithms to synthesize, summarize, and elevate relevant clinical data from EHRs like Cerner, Epic, or athenahealth, as well as other data sources.Wellsheet's Smart EHR UI predicts and prioritizes the most pertinent data based on a clinician's specialty and workflow habits, assembling it in an intuitive and customizable manner. This enables providers to quickly arrive at accurate clinical insights without compromising patient interactions. By embedding within existing EHRs, the solution helps clinicians understand what needs to be done and make more informed decisions while reducing errors.As of July 2022, Wellsheet had an enterprise-wide deployment with over 10,000 clinicians using its interface, reducing the time spent in EHRs for physicians, nurses, and care managers. The company's FHIR-based APIs allow for rapid implementation across multiple data sources within weeks and minimal training requirements.

Redox is a leading healthcare technology company that provides a secure and efficient platform for exchanging healthcare data. Its core offering is an integration engine that enables seamless connectivity between various healthcare systems, electronic health records (EHRs), and digital health applications. By acting as a single, standardized API endpoint, Redox simplifies the complex process of interoperability, allowing healthcare organizations to share and access patient data seamlessly.
Redox's platform is built on a standardized data model format, utilizing HTTPS communication with JSON to facilitate secure and convenient integration for healthcare applications. The company's ecosystem encompasses a vast network of over 2,000 healthcare delivery organizations, 350 healthcare software vendors, and connections to more than 90 EHR systems. This extensive reach enables Redox's customers, including payers, providers, and digital health companies, to exchange data with a wide range of healthcare stakeholders.
The company's offerings include Redox Nexus, a managed integration platform that facilitates interoperability between legacy formats and the current FHIR standard; Redox Nova, which enables cloud-based data integration and translation of legacy standards into FHIR; Redox Access, which connects to national clinical networks like Carequality and DirectTrust for seamless clinical data exchange; and Redox Chroma, an Enterprise Master Patient Index (EMPI) solution that aggregates patient records across multiple data sources.
Key customers and partnerships
Redox has established partnerships with leading healthcare organizations and companies, including Mytonomy, a video-based patient engagement company. Mytonomy leverages Redox's integration capabilities to synchronize the assignment and viewership of its educational video modules with health system EHRs, ensuring seamless documentation of patient education activities.
Furthermore, Redox has collaborated with Columbia University Medical Center's Department of Cardiology, enabling the integration of Mytonomy's patient education platform with the center's EHR system.
The company has also forged alliances with healthcare consulting firms like Productive Edge, providing joint solutions for healthcare data integration and strategy development.

Redox

Moxe Health, based in Madison, WI, is a healthcare interoperability company that utilizes innovative technology to simplify and improve the secure exchange of clinical data and crucial insights between healthcare payers and providers. Through its API-enabled solutions compatible with leading electronic health records (EHRs), Moxe fosters meaningful collaboration within the healthcare ecosystem by connecting various stakeholders and facilitating faster, more cost-effective data exchange.
The company's digital release of information (ROI) product automates requests for medical charts, enabling providers to securely fulfill such requests in seconds, eliminating manual processes, paper, faxes, and phone calls. Additionally, Moxe's convergence product allows payers to input their insights directly into the EHR for providers to access. By streamlining data sharing, Moxe empowers providers and payers to optimize operations, improve accuracy, and deliver better financial and clinical outcomes.
As of June 2022, Moxe's network connected major health systems, national health plans representing over 75 million lives, leading third-party requestors, and more than 60 hospital systems. The company aimed to accelerate its mission of advancing interoperability and making healthcare more affordable by eliminating administrative waste through its patient-centric solutions.
Key customers and partnerships
Moxe Health partners with leading healthcare organizations, including Allscripts, whose Allscripts Sunrise EHR users can leverage Moxe's Digital ROI solution for efficient data exchange between health systems, payers, and third-party requestors.

Moxe Health

Particle Health is a developer-friendly API platform that aggregates and standardizes data from over 270 million patients' medical records across thousands of healthcare sources in the US. The company's comprehensive API enables healthcare providers and digital health companies to easily obtain clinical data points and actionable patient health insights through a single integration. Particle Health's technology performs patient matching behind the scenes to connect accounts within HIPAA authorization, overcoming the challenges of accessing medical records across different portals and providers.
Since its inception, Particle Health has achieved significant milestones, including a 90% success rate in finding patient records and an average of 105 records per patient search as of July 2022. The company has expanded its offering beyond electronic medical records (EMRs) to include data sources such as pharmacy records, admission, discharge, and transfer (ADT) notifications, and billing claims data, with plans to integrate genomics and other sources in the future.
Key customers and partnerships
Particle Health has formed notable partnerships and collaborations with various healthcare companies and organizations. For instance, xCures, a technology platform that uses artificial intelligence and predictive modeling to identify and rank treatment options for cancer patients, has integrated Particle Health's Specialty Search capabilities. This integration allows xCures to efficiently access comprehensive oncology data, leading to a significant increase in program enrollment and better patient care management.
Another strategic partnership was announced in November 2023 between Particle Health and Hona, a customizable AI product that converts health records into concise patient overviews. By integrating Particle Health's API for medical record retrieval, Hona can analyze and present a complete view of a patient's health history, enabling providers to make informed clinical decisions and streamline care encounters.

Particle Health

Verto Health is a Canadian digital health company that offers a Digital Twin Orchestration Platform. Its patented machine learning technology consolidates data from various sources to create normalized, contextual snapshots – known as 'Digital Twins' – of each patient's healthcare journey. Verto's platform then automates actions across different systems while securely managing consent, data, and communication.
In October 2022, Unity Health Toronto implemented Verto's technology to help manage ambulatory patient flow, streamline consent management, and transform patient experience across dozens of ambulatory clinics. Verto's solution allowed Unity Health to coordinate and engage with patients before, during, after, and in-between hospital visits, supporting care pathway management and enhancing the patient experience.
Key customers and partnerships
In July 2023, Verto Health partnered with the Centre for Addiction and Mental Health (CAMH) to develop a web-based Digital Front Door platform. This platform aimed to digitize the patient journey and support data-driven, measurement-based care for CAMH's patients and care providers. The collaboration involved co-designing, configuring, and implementing the Digital Front Door to act as a single-point of entry for CAMH patients and families, enabling virtual care and integrating various patient-facing information systems.

Verto Health

Includes tools that allow healthcare providers to aggregate clinical data (both structured and unstructured) from a variety of sources and share this information with other providers, patients, or insurance providers.

Platforms that provide interoperability APIs and developer toolkits that allow siloed healthcare applications or systems to communicate with each other. Targeted at both healthcare providers and digital health apps.

Software platforms that integrate patient information (including social determinants of health) from multiple sources to digital tools. These tools support patient management and offer actionable insights on a patient's health by leveraging data analytics.

Healthcare data is exchanged, shared, and interpreted via digital mediums

AI/ML algorithms aggregate and standardize data for seamless sharing between healthcare systems

IoT technology is being used to improve hospital interoperability, connectivity, and secure data sharing

Wellsheet

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless